Pipeline

Our DARPin^® platform has vast applicability across a range of diseases. Explore our pipeline:

Candidate (Targets)

Research

Preclinical

Phase 1

Phase 2

Phase 3

Rights

Ensovibep (MP0420) / COVID-19

Phase 3

MP0423 / COVID-19

Preclinical

AMG 506 (MP0310) (FAP x 4-1BB)

Phase 1

MP0317 (FAP x CD-40)

Preclinical

AML CD3 x CD33 x CD70 x CD123

Preclinical

Abicipar for nAMD

Phase 3

Abicipar for DME

Phase 2

Platform Discovery Areas

T-Cell Engagers

Preclinical

Additional Infectious Diseases

Research